The study will comprise of three groups of children (n=40): 1. A group receiving a novel short-term dynamic play therapy. 2. Dyadic therapy 3. Control group who will not receive therapy. All children will be assessed for psychopathology (anxiety, depression and behavioral problems) using standardized instruments such as semi-structured interview and self-reported questionnaires; Cortisol (CT), Dehydroepiandrosterone (DHEA), Oxytocin (OT) and Secretory Immunoglobulin A (SIgA) will be assessed by using saliva sampling; and father-mother-child interactions will be videotaped and analyzed. Narrative descriptions will be obtained from parents, and the interviews recorded for voice analysis. Assessment will be made at baseline and then bi-monthly for six months.
Anxiety disorders are the most common disorders across the lifespan and tend to have both an early onset and persistent course throughout life. Since the preschool years mark a sensitive period for the development and exacerbation of anxiety symptoms in children, which often persist throughout childhood and adolescence, there is an urgent need to understand this condition in the most detailed manner and find efficient therapeutic solutions. In this Randomized control study (RCT), the investigators will test the efficacy of two interventions for childhood anxiety disorders: a special emotion-focused therapy and a dyadic parent-child intervention.
DESGIN Recruitment: consecutive admissions to the preschool clinic at the Intradisciplinary Center at Herzliya will be asked to participate in the study.
Baseline Diagnosis:
Consecutive referrals to the clinic will be recruited for the study and will be randomly and blindly allotted to each treatment arm.
Both therapies would have the same duration of 6 months and will consist of 24 weekly meetings for the child or child-parent dyad, accompanied by 12 bi-weekly meetings with both parents. Each session will last for approximately 50 min.
EVALUATION All children will be evaluated at baseline, at bi-monthly intervals during treatment, and at termination (at 6 months). The evaluation session will be conducted in a university laboratory (not in the clinical setting) by RA unfamiliar to the child.
Dropouts will be noted and as far as possible the details for discontinuing will be recoded.
The following dimensions will be emphasized:
In addition, other dimensions will also be noted and scored, as listed in the CIB manual.
2. Mother-Father Relationship: five minutes of Conflictual Discussion between and father will be videotaped and coded.
3. Child Emotion Regulation: the child's ability to regulate his emotions will be rated using the child's reaction to a challenging task, such as the puzzle task. Micro-coding of child behavior during the puzzle task paradigm will be conducted on a computerized system (Noldus Co, Waggeniggen, The Netherlands). Codes are based on our own and others' research with preschoolers . Child's Self-Regulation will be represented by the sum of time proportions of each of the following behaviors: withdrawal, gaze aversion, physical self-soothing and solitary substitutive play.
In addition, parents will fill out the Toddler Behavior Assessment Questionnaire (TBAQ), . This questionnaire includes the assessment of child's temperament, emotion regulation, self-soothing and inhibition control.
4. Parental Representation of Child and the Treatment: Narrative descriptions will be obtained from parents, and the interviews recorded for voice analysis. Parents will answer three questions: 1. "Describe your child"; 2. "Describe your child's problems"; 3. "How do you think the therapy will help or helps addressing your child's difficulties".
5. Biological Measures:
OT: Oxytocin is a hormone which appears to be a marker of affiliation and relationship. It has been shown to be disturbed in conditions where parent-child relationships are impaired.
CT: is a well known and much studied marker of stress and anxiety. DHEA: this hormone has also been shown by our group and others to be related to stress and emotional regulation.
Hormonal Analysis:
OT: The liquid samples will be stored at 80C. To concentrate samples by 3 or 4 times, the liquid samples would be lyophilized over-night and kept in 20C until assayed. Dry samples will be reconstructed in the assay buffer immediately before analysis by EIA. Determination of OT was performed by commercial OT ELISA kit (Assay Design, MI, USA).
CT: The samples will be stored at -20C until assayed. Cortisol levels will be assayed using a commercial ELISA kit (Assay Design, MI).
DHEA: In-order to precipitate the saliva, samples will undergo several freeze-thaw cycles. After the fourth cycle the tubes will be centrifuged at 1500 x g (@3000 rpm) for 20 minutes. Supernatants will be stored at -20C until assayed. Determination of DHEA will be performed using a commercial DHEA ELISA kit (Salimetrics, USA). Salimetrics DHEA kit is a competitive immunoassay specifically designed for the quantitative measurement of salivary DHEA. On the day of assay, samples will be thawed, and 50 micro-liters will pipette into the appropriate well of the kit.
Immunological measures:
SIgA: there is a strong relationship between the immunological system and stress. the investigators will therefore assay SIgA, which has also been studied in stressful situations.
Immunological measure analysis:
Determination of s-IgA will be performed using a commercial s-IgA ELISA kit (EUROIMMUN AG: 23560, Luebeck, Germany). The kit provides quantitative in vitro assay for s-IgA in human saliva. On day of assay, samples will be thawed completely and diluted 1:201 in sample buffer and further measured according the kit's instructions. Measurements were performed in duplicate and the concentrations of samples were calculated by using matrix laboratory (MATLAB 7) according to relevant standard curves. The intra-assay coefficient of samples and controls was 8.1%, and inter-assay coefficients for samples and controls were less than 11.6%.
Statistics all variables will be entered into a data base and then into SPSS. The major hypothesis will be the relative efficacy of the two interventions would be compared to control, evaluating symptoms reduction, hormonal level changes and enhancing parental sensitivity (among other changes in parental behavior). The investigators will perform variance analysis, correlations, regression and HLM models that will describe the changes in these variables in each group (two intervention and one control) along the check up points (baseline, every two months and at ending point).
Condition | Childhood Anxiety Disorder |
---|---|
Treatment | IWOTCH, Dyadic therapy, Dyadic therapy |
Clinical Study Identifier | NCT04978844 |
Sponsor | Interdisciplinary Center Herzliya |
Last Modified on | 10 August 2021 |
,
You have contacted , on
Your message has been sent to the study team at ,
You are contacting
Primary Contact
Additional screening procedures may be conducted by the study team before you can be confirmed eligible to participate.
Learn moreIf you are confirmed eligible after full screening, you will be required to understand and sign the informed consent if you decide to enroll in the study. Once enrolled you may be asked to make scheduled visits over a period of time.
Learn moreComplete your scheduled study participation activities and then you are done. You may receive summary of study results if provided by the sponsor.
Learn moreEvery year hundreds of thousands of volunteers step forward to participate in research. Sign up as a volunteer and receive email notifications when clinical trials are posted in the medical category of interest to you.
Sign up as volunteer
Lorem ipsum dolor sit amet consectetur, adipisicing elit. Ipsa vel nobis alias. Quae eveniet velit voluptate quo doloribus maxime et dicta in sequi, corporis quod. Ea, dolor eius? Dolore, vel!
No annotations made yet
Congrats! You have your own personal workspace now.